Starting or Switching to an Integrase Inhibitor-Based Regimen Affects PTSD Symptoms in Women with HIV
Asante R. Kamkwalala, Kunbo Wang, Jane A. O’Halloran, Dionna W. Williams, Raha Dastgheyb, Kathryn C. Fitzgerald, Amanda B. Spence, Pauline M. Maki, Deborah Gustafson, Joel Milam, Anjali Sharma, Kathleen M. Weber, Adaora A. Adimora, Igho Ofotokun, Anandi N. Sheth, Cecile D. Lahiri, Margaret A. Fischl, Deborah Konkle‐Parker, Yanxun Xu, Leah H. Rubin
Topics & Concepts
RaltegravirRegimenDolutegravirElvitegravirAnxietyAbacavirSomatizationIntegrase inhibitorPopulationMedicineMoodInternal medicinePsychologyPsychiatryClinical psychologyViral loadHuman immunodeficiency virus (HIV)ImmunologyAntiretroviral therapyEnvironmental healthHIV/AIDS Research and InterventionsBipolar Disorder and TreatmentMaternal Mental Health During Pregnancy and Postpartum